Abstract
The purpose of this study was to compare the dosimetric characteristics for hippocampal avoidance (HA) between the treatment plans based on fused CT and MRI imaging during whole brain radiotherapy (WBRT) pertaining to: (1) 3-dimensional conformal radiotherapy (3D-CRT), (2) dynamic intensity modulated radiation therapy (dIMRT), and (3) RapidArc for patients with brain metastases. In our study, HA was defined as hippocampus beyond 5 mm, and planning target volume (PTV) was obtained subtracting HA volume from the volume of whole brain. There were 10 selected patients diagnosed with brain metastases receiving WBRT. These patients received plans for 3D-CRT (two fields), dIMRT (seven non-coplanar fields) and RapidArc (dual arc). The prescribed dose 30 Gy in 10 fractions was delivered to the whole-brain clinical target volume of patients. On the premise of meeting the clinical requirements, we compared target dose distribution, target coverage (TC), homogeneity index (HI), dose of organs at risk (OARs), monitor units (MU) and treatment time between the above three radiotherapy plans. V90 %, V95 % and TC of PTV for 3D-CRT plan were lowest of the three plans. V90 %, V95 % and HI of PTV in RapidArc plan were superior to the other two plans. TC of PTV in RapidArc plan was similar with dIMRT plan (P > 0.05). 3D-CRT was the optimal plan in the three plans for hippocampal protection. The median dose (Dmedian) and the maximum doses (Dmax) of hippocampus in 3D-CRT were 4.95, 10.87 Gy, which were lowest among the three planning approaches (P < 0.05). Dmedian and Dmax of hippocampus in dIMRT were 10.68, 14.11 Gy. Dmedian and Dmax of hippocampus in RapidArc were 10.30 gGy, 13.92 Gy. These parameters of the last two plans pertain to no significant difference (P > 0.05). When WBRT (30 Gy,10F) was equivalent to single dose 2 Gy,NTDmean of hippocampus in 3D-CRT, dIMRT and RapidArc were reduced to 3.60, 8.47, 8.20 Gy2, respectively. In addition, compared with dIMRT, MU of RapidArc was reduced and the treatment time was shortened by nearly 25 %. All three radiotherapy planning approaches in our study can meet the clinical requirements of HA. Although TC in 3D-CRT was lowest, hippocampus was protected best by this plan. So many radiation fields and the design of non-coplanar fields lead to the complication of dIMRT. TC and HI in RapidArc were superior to the other two plans with the precise of meeting the clinical requirements. The difference in protection for hippocampus between dIMRT and RapidArc was statistically significant. In addition, RapidArc can remarkably reduce MU and the treatment time.
Similar content being viewed by others
References
Bullard DE, Cox EB, Seigler HF (1981) Central nervous system metastases in malignant melanoma. Neurosurgery 8(1):26–30
Mehta M, Hoban P, Mackie TR (2009) Commissioning and quality assurance of rapidarc radiotherapy delivery system: In Regard to Ling Et Al. (Int J Radiat Oncol Biol Phys 2008;72:575–581): Absence of data does not constitute proof; the proof is in tasting the pudding. Int J Radiat Oncol Biol Phys 75(1):4–6
Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases—a randomized controlled trial. Jama-J Am Med Assoc 295(21):2483–2491
Gore EM, Bae K, Wong SJ et al (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 29(3):272–278
Mehta MP, Tsao MN, Whelan TJ et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63(1):37–46
Truc G, Martin E, Mirjolet C, Chamois J, Petitfils A, Crehange G (2013) The role of whole brain radiotherapy with hippocampal-sparing. Cancer Radiother 17(5–6):419–423
Roman DD, Sperduto PW (1995) Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys 31(4):983–998
DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39(6):789–796
Harth S, Abo-Madyan Y, Zheng L et al (2013) Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy. Radiother Oncol 109(1):152–158
Lin SY, Yang CC, Wu YM, et al (2015) Evaluating the impact of hippocampal sparing during whole brain radiotherapy on neurocognitive functions: a preliminary report of a prospective phase II study. Biomed J
Gondi V, Pugh SL, Tome WA et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32(34):3810–3816
Gondi V, Tome WA, Marsh J et al (2010) Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol 95(3):327–331
Ghia A, Tome WA, Thomas S et al (2007) Distribution of brain metastases in relation to the hippocampus: implications for neurocognitive functional preservation. Int J Radiat Oncol Biol Phys 68(4):971–977
Chera BS, Amdur RJ, Patel P, Mendenhall WM (2009) A radiation oncologist’s guide to contouring the hippocampus. Am J Clin Oncol 32(1):20–22
Gondi V, Tolakanahalli R, Mehta MP et al (2010) Hippocampal-sparing whole-brain radiotherapy: a “how-to” technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 78(4):1244–1252
Knisely JP, Yu JB (2011) Hippocampal-sparing whole-brain radiotherapy: a “how-to” technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: in regard to Gondi v, et al. (Int J Radiat Oncol Biol Phys 2010;78:1244–1252). Int J Radiat Oncol Biol Phys 79(3):957–958; author reply 958
Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR (2003) Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 63(14):4021–4027
Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8(9):955–962
Giaj Levra N, Sicignano G, Fiorentino A, et al (2015) Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study. Radiol Med
Gondi V, Tolakanahalli R, Mehta MP, Tome WA (2011) Hippocampal-sparing whole-brain radiotherapy: a “How-to” technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy: In Regard to Gondi V, et al. (Int J Radiat Oncol Biol Phys 2010;78:1244–1252) Response. Int J Radiat Oncol Biol Phys. 79(3):958
Nevelsky A, Ieumwananonthachai N, Kaidar-Person O et al (2013) Hippocampal-sparing whole-brain radiotherapy using Elekta equipment. J Appl Clin Med Phys. 14(3):4205
Otto K (2008) Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 35(1):310–317
Willins J, Kachnic L (2008) Re: Intensity-modulated radiation therapy dose prescription, recording, and delivery: Patterns of variability among institutions and treatment planning systems—response. J Natl Cancer Inst 100(17):1266–1267
Wong KKL, Tu J, Sun Z, Dissanayake DW (2013) Methods in research and development of biomedical devices. World Scientific, New Jersey
Wong KK, Chu WC (2015) Ethics policies and procedures in imaging and interventional radiology. Australas Phys Eng Sci Med 38(2):375–376
Duthoy W, De Gersem W, Vergote K et al (2004) Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 60(3):794–806
Vanetti E, Clivio A, Nicolini G et al (2009) Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol 92(1):111–117
van Kesteren Z, Belderbos J, van Herk M et al (2012) A practical technique to avoid the hippocampus in prophylactic cranial irradiation for lung cancer. Radiother Oncol 102(2):225–227
Palma D, Vollans E, James K et al (2008) Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 72(4):996–1001
Cozzi L, Dinshaw KA, Shrivastava SK (2008) A treatment planning study comparing volumetric arc modulation with RapidArc and fxed feld IMRT for cervix uteri radiotherapy. Radiother Oncol 89:180–191
Chiesa S, Balducci M, Azario L et al (2013) Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy. Biomed Res Int 2013:568597
Acknowledgments
This work was supported by the project of Yangzhou Science and Technology Bureau (No. YZ2011085) and the“333” Training Foundation of Jiangsu Province, China (No. BRA2014158).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, BH., Hua, W., Gu, X. et al. Dosimetric study of different radiotherapy planning approaches for hippocampal avoidance whole-brain radiation therapy (HA-WBRT) based on fused CT and MRI imaging. Australas Phys Eng Sci Med 38, 767–775 (2015). https://doi.org/10.1007/s13246-015-0397-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13246-015-0397-7